Genome-Wide DNA Methylation Profiles in Noncancerous Gastric Mucosae with Regard to Helicobacter pylori Infection and the Presence of Gastric Cancer

Helicobacter

Volumn 16, Issue 3, 2011, Pages 179-188

  Shin, Cheol Min ^a   Kim, Nayoung ^a,b   Jung, Younmu ^a   Park, Ji Hyun ^b   Kang, Gyeong Hoon ^b   Park, Woong Yang ^b   Kim, Joo Sung ^b   Jung, Hyun Chae ^b   Song, In Sung ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Gastric cancer; Helicobacter pylori; Methylation

Indexed keywords

BIOLOGICAL MARKER; BISULFITE; GENOMIC DNA;

AGED; ARTICLE; BACTERIUM CULTURE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; CRK GENE; DCC GENE; DNA METHYLATION; DNA MICROARRAY; DNA MODIFICATION; FEMALE; GENE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MALE; MOS GENE; NONHUMAN; PRIORITY JOURNAL; PTPN 6 GENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA;

AGED; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; FEMALE; GASTRIC MUCOSA; GENOME; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 79956062605     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2011.00838.x     Document Type: Article

References (28)

1. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4:988-93.
2. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
3. Park SY, Yoo E, Cho NY, et al. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection. J Pathol 2009;219:410-6.
4. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006;20:633-49.
5. Won YJ, Sung J, Jung KW, et al. Nationwide Cancer Incidence in Korea, 2003-2005. Cancer Res Treat 2009;41:122-31.
6. Ushijima T. Epigenetic field for cancerization. J Biochem Mol Biol 2007;40:142-50.
7. Shin CM, Kim N, Jung Y, et al. Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis. Cancer Sci 2010;101:1337-46.
8. Nakajima T, Yamashita S, Maekita T, et al. The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. Int J Cancer 2009;124:905-10.
9. Lim JH, Kim SP, Gabrielson E, et al. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation. Int J Cancer 2005;116:200-6.
10. Oshimo Y, Nakayama H, Ito R, et al. Promoter methylation of cyclin D2 gene in gastric carcinoma. Int J Oncol 2003;23:1663-70.
11. Mesquita P, Peixoto AJ, Seruca R, et al. Role of site-specific promoter hypomethylation in aberrant MUC2 mucin expression in mucinous gastric carcinomas. Cancer Lett 2003;189:129-36.
12. Akiyama Y, Maesawa C, Ogasawara S, et al. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol 2003;163:1911-19.
13. Shivapurkar N, Gazdar AF. DNA methylation based biomarkers in non-invasive cancer screening. Curr Mol Med 2010;10:123-32.
14. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
15. Irizarry RA, Ladd-Acosta C, Carvalho B, et al. Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res 2008;18:780-90.
16. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-26.
17. Nishigaki M, Aoyagi K, Danjoh I, et al. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. Cancer Res 2005;65:2115-24.
18. Maekita T, Nakazawa K, Mihara M, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 2006;12:989-95.
19. Chan AO, Lam SK, Wong BC, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003;52:502-6.
20. Kang HY, Kim N, Park YS, et al. Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa. Dig Dis Sci 2006;51:2310-15.
21. Kanai Y. Genome-wide DNA methylation profiles in precancerous conditions and cancers. Cancer Sci 2010;101:36-45.
22. Nakajima T, Enomoto S, Yamashita S, et al. Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication. J Gastroenterol 2010;45:37-44.
23. Tahara T, Arisawa T, Shibata T, et al. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Digestion 2007;75:54-61.
24. Ushijima T, Nakajima T, Maekita T. DNA methylation as a marker for the past and future. J Gastroenterol 2006;41:401-7.
25. Nakajima T, Maekita T, Oda I, et al. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol Biomarkers Prev 2006;15:2317-21.
26. Fan JB, Oliphant A, Shen R, et al. Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol 2003;68:69-78.
27. Hernandez-Vargas H, Lambert MP, Le Calvez-Kelm F, et al. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PLoS ONE 2010;5:e13688.
28. Lee JH, Kim N, Chung JI, et al. Long-term follow up of Helicobacter pylori IgG serology after eradication and reinfection rate of H. pylori in South Korea. Helicobacter 2008;13:288-94.